These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1665474)

  • 1. [Herpes simplex virus retinitis. Role of the immune system in the animal experiment].
    Zierhut M; Tamesis R; Hemady R; Foster CS
    Fortschr Ophthalmol; 1991; 88(6):740-7. PubMed ID: 1665474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depletion of T-lymphocyte subsets in murine herpes-simplex-virus retinitis.
    Zierhut M; Soukasian S; Zhao TZ; Tamesis RR; Foster CS
    Ger J Ophthalmol; 1992; 1(3-4):145-50. PubMed ID: 1362368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cells in the uninjected eye after anterior chamber inoculation of herpes simplex virus type 1.
    Azumi A; Atherton SS
    Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):78-83. PubMed ID: 9430548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of murine herpes simplex virus type 1 retinitis in the uninoculated eye by CD4+ T lymphocytes.
    Azumi A; Cousins SW; Kanter MY; Atherton SS
    Invest Ophthalmol Vis Sci; 1994 Jan; 35(1):54-63. PubMed ID: 7905467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for T lymphocytes in preventing experimental herpes simplex virus type 1-induced retinitis.
    Whittum-Hudson J; Farazdaghi M; Prendergast RA
    Invest Ophthalmol Vis Sci; 1985 Nov; 26(11):1524-32. PubMed ID: 3877027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1.
    Morrison LA; Knipe DM
    Virology; 1997 Dec; 239(2):315-26. PubMed ID: 9434723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of natural killer cells and interferon in resistance to acute infection of mice with herpes simplex virus type 1.
    Bukowski JF; Welsh RM
    J Immunol; 1986 May; 136(9):3481-5. PubMed ID: 2420892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinitis and deviant immune responses following intravitreal inoculation of HSV-1.
    Atherton SS; Pesicka GA; Streilein JW
    Invest Ophthalmol Vis Sci; 1987 May; 28(5):859-66. PubMed ID: 3032839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors.
    Colmenares C; Lopez C
    J Immunol; 1986 May; 136(9):3473-80. PubMed ID: 2420891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An immunogenetic analysis of resistance to herpes simplex virus retinitis in inbred strains of mice.
    Pepose JS; Whittum-Hudson JA
    Invest Ophthalmol Vis Sci; 1987 Sep; 28(9):1549-52. PubMed ID: 3040616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Fas and Fas ligand deficiency in resistance of C57BL/6 mice to HSV-1 keratitis and chorioretinitis.
    Nguyen QD; Uy HS; Merchant A; Medina CA; Baltatzis S; Zhao T; Zhao ZS; Cantor H; Foster CS
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2505-9. PubMed ID: 11581190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes simplex virus type 1 alters transcript levels of tumor necrosis factor-alpha and interleukin-6 in retinal glial cells.
    Drescher KM; Whittum-Hudson JA
    Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2302-12. PubMed ID: 8843914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of natural killer cells in the development of herpes simplex virus type 1 induced stromal keratitis in mice.
    Tamesis RR; Messmer EM; Rice BA; Dutt JE; Foster CS
    Eye (Lond); 1994; 8 ( Pt 3)():298-306. PubMed ID: 7958034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-dependent cellular cytotoxicity against cells infected with herpes simplex virus type 1 in Igh-1 disparate congenic mice.
    Tamesis RR; Rodriguez A; Hoang-Xuan T; Foster CS
    Ger J Ophthalmol; 1993 Aug; 2(4-5):218-23. PubMed ID: 8220102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistopathologic findings in herpes simplex virus chorioretinitis in the von Szily model.
    Zaltas MM; Opremcak EM; Hemady R; Foster CS
    Invest Ophthalmol Vis Sci; 1992 Jan; 33(1):68-77. PubMed ID: 1309731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonneutralizing antibody against the glycoprotein K of herpes simplex virus type-1 exacerbates herpes simplex virus type-1-induced corneal scarring in various virus-mouse strain combinations.
    Ghiasi H; Cai S; Slanina S; Nesburn AB; Wechsler SL
    Invest Ophthalmol Vis Sci; 1997 May; 38(6):1213-21. PubMed ID: 9152241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of potent antitumor natural killer cell activity by herpes simplex virus-thymidine kinase and ganciclovir therapy in an orthotopic mouse model of prostate cancer.
    Hall SJ; Sanford MA; Atkinson G; Chen SH
    Cancer Res; 1998 Aug; 58(15):3221-5. PubMed ID: 9699645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of T cell receptor V beta gene expression in B cell deficient mice after experimental herpes simplex virus keratitis.
    Arrunategui-Correa V; Dutt JE; Foster CS
    Acta Virol; 1997 Jun; 41(3):145-52. PubMed ID: 9385402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of NK cells in protection of mice against herpes simplex virus-1 infection.
    Rager-Zisman B; Quan PC; Rosner M; Moller JR; Bloom BR
    J Immunol; 1987 Feb; 138(3):884-8. PubMed ID: 3805719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cellular cytotoxicity against herpes simplex virus-infected cells in Igh-1-disparate mice.
    Tamesis RR; Foster CS
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2224-9. PubMed ID: 1700771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.